Search Results - "Mühlberger, Nikolai"

Journal Article

Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions

by Loeb, Stacy Zhou, Qinlian Siebert, Uwe Rochau, Ursula Jahn, Beate Mühlberger, Nikolai Carter, H. Ballentine Lepor, Herbert Braithwaite, R. Scott Published in European urology (01.12.2017)

“...An increasing proportion of prostate cancer is being managed conservatively. However, there are no randomized trials or consensus regarding the optimal...”

Journal Article

by Siebert Uwe Zeuzem Stefan Sroczynski Gaby Lettmeier Beate Schwarzer Ruth Mühlberger Nikolai Published in BMC public health (01.01.2009)

“...Abstract Background Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-stage cirrhosis, and liver cancer, but little is known about the...”

Fulltext

Journal Article

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria

by Jahn, Beate Sroczynski, Gaby Bundo, Marvin Mühlberger, Nikolai Puntscher, Sibylle Todorovic, Jovan Rochau, Ursula Oberaigner, Willi Koffijberg, Hendrik Fischer, Timo Schiller-Fruehwirth, Irmgard Öfner, Dietmar Renner, Friedrich Jonas, Michael Hackl, Monika Ferlitsch, Monika Siebert, Uwe Published in BMC gastroenterology (05.12.2019)

“...Clear evidence on the benefit-harm balance and cost effectiveness of population-based screening for colorectal cancer (CRC) is missing. We aim to...”

Fulltext

Journal Article

Market uptake of new antiviral drugs for the treatment of hepatitis C

by Lettmeier, Beate Mühlberger, Nikolai Schwarzer, Ruth Sroczynski, Gaby Wright, Davene Zeuzem, Stefan Siebert, Uwe Published in Journal of hepatology (2008)

“...Background/Aims Peginterferon plus ribavirin is the state-of-the-art antiviral therapy for prevention of serious complications of hepatitis C. Our aim was to...”

eBook

Hodenkrebs: führt eine regelmäßige Früherkennungsuntersuchung für Männer ab 16 Jahren zu besseren Behandlungsergebnissen? : HTA-Nummer: HT18-01
Version: 1.0, Stand: 18.06.2020

by Mühlberger, Nikolai
2020

Fulltext

Journal Article

The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany

by Schaffner, Monika Rochau, Ursula Mühlberger, Nikolai Conrads-Frank, Annette Qerimi Rushaj, Vjollca Sroczynski, Gaby Koukkou, Eftychia Thuesen, Betina Heinsbaek Völzke, Henry Oberaigner, Wilhelm Siebert, Uwe Published in Endocrine Connections (01.01.2021)

“...Objective More than 30% of the German population suffers from mild to moderate iodine deficiency causing goiter and other iodine deficiency disorders (IDDs)...”

Journal Article

The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening

by Mühlberger, Nikolai Kurzthaler, Christina Iskandar, Rowan Krahn, Murray D Bremner, Karen E Oberaigner, Willi Klocker, Helmut Horninger, Wolfgang Conrads-Frank, Annette Sroczynski, Gaby Siebert, Uwe Published in Medical decision making (01.08.2015)

“...Background. The ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) model is a state-transition microsimulation model evaluating the benefits and harms of...”

Fulltext

Journal Article

Patient-Reported Urinary Incontinence and Erectile Dysfunction Following Radical Prostatectomy: Results from the European Prostate Centre Innsbruck

by Geiger-Gritsch, Sabine Oberaigner, Wilhelm Mühlberger, Nikolai Siebert, Uwe Ladurner, Michael Klocker, Helmut Horninger, Wolfgang Published in Urologia internationalis (01.05.2015)

“...Introduction: Urinary and erectile functions were assessed by using self-administered validated questionnaires in patients undergoing radical prostatectomy...”

Journal Article

Cost-effectiveness of primarily human papillomavirus–based cervical cancer screening in settings with currently established Pap screening: A systematic review commissioned by the G...

by Mühlberger, Nikolai Sroczynski, Gaby Esteban, Eva Mittendorf, Thomas Miksad, Rebecca A Siebert, Uwe Published in International journal of technology assessment in health care (01.04.2008)

“...Objectives: The aim of this study was to summarize the current evidence for the cost-effectiveness of primarily human papillomavirus (HPV) -based cervical...”

Fulltext

Journal Article

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation

by Jahn, Beate Sroczynski, Gaby Bicher, Martin Rippinger, Claire Mühlberger, Nikolai Santamaria, Júlia Urach, Christoph Schomaker, Michael Stojkov, Igor Schmid, Daniela Weiss, Günter Wiedermann, Ursula Redlberger-Fritz, Monika Druml, Christiane Kretzschmar, Mirjam Paulke-Korinek, Maria Ostermann, Herwig Czasch, Caroline Endel, Gottfried Bock, Wolfgang Popper, Nikolas Siebert, Uwe Published in Vaccines (Basel) (27.04.2021)

“...(1) Background: The Austrian supply of COVID-19 vaccine is limited for now. We aim to provide evidence-based guidance to the authorities in order to minimize...”

Fulltext

Journal Article

The low and declining risk of malaria in travelers to Latin America: is there still an indication for chemoprophylaxis?

by Behrens, Ron H Carroll, Bernadette Beran, Jiri Bouchaud, Olivier Hellgren, Urban Hatz, Christoph Jelinek, Tomas Legros, Fabrice Mühlberger, Nikolai Myrvang, Bjørn Siikamäki, Heli Visser, Leo Published in Malaria journal (23.08.2007)

“...A comparison was made between local malaria transmission and malaria imported by travellers to identify the utility of national and regional annual parasite...”

Fulltext

Journal Article

Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infection

by Sroczynski, Gaby Esteban, Eva Conrads-Frank, Annette Schwarzer, Ruth Mühlberger, Nikolai Wright, Davene Zeuzem, Stefan Siebert, Uwe Published in European journal of public health (01.06.2009)

“...Background: Hepatitis C virus (HCV) infection is an emerging problem in public health. In most countries, the majority of HCV infected people are yet...”

Fulltext

Journal Article

Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment

by Blatt, Carine Raquel Storb, Bernd Mühlberger, Nikolai Farias, Mareni Rocha Siebert, Uwe Published in Brazilian Journal of Pharmaceutical Sciences (01.04.2014)

“...Brazilian Guidelines to HCV treatment (2007) recommended that the first choice treatment for patients with chronic hepatitis C (CHC) and genotype 2 or 3 is...”

Fulltext

Journal Article

The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases

by Mangen, Marie-Josee J Plass, Dietrich Havelaar, Arie H Gibbons, Cheryl L Cassini, Alessandro Muhlberger, Nikolai van Lier, Alies Haagsma, Juanita A Brooke, R. John Lai, Taavi de Waure, Chiara Kramarz, Piotr Kretzschmar, Mirjam E. E
edited by Kirk, Martyn
Published in PloS one (20.11.2013)

“...In 2009, the European Centre for Disease Prevention and Control initiated the 'Burden of Communicable Diseases in Europe (BCoDE)' project to generate...”

Journal Article

by Mühlberger, Nikolai Schwarzer, Ruth Lettmeier, Beate Sroczynski, Gaby Zeuzem, Stefan Siebert, Uwe Published in BMC public health (22.01.2009)

“...Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-stage cirrhosis, and liver cancer, but little is known about the burden of disease...”

Fulltext

Journal Article

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model

by Mühlberger, Nikolai Boskovic, Kristijan Krahn, Murray D Bremner, Karen E Oberaigner, Willi Klocker, Helmut Horninger, Wolfgang Sroczynski, Gaby Siebert, Uwe Published in BMC public health (26.06.2017)

“...A recent recalibration of the ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) Model, assuming that latent prostate cancer (PCa) detectable at autopsy might...”

Fulltext

Journal Article

Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators

by Wichmann, Ole Gascon, Joaquim Schunk, Mirjam Puente, Sabino Siikamaki, Heli Gjø, Ida Lopez-Velez, Rogelio Clerinx, Joannes Peyerl-Hoffmann, Gabriele Sundøy, Anders Genton, Blaise Kern, Peter Calleri, Guido de Górgolas, Miguel Mühlberger, Nikolai Jelinek, Tomas Published in The Journal of infectious diseases (15.04.2007)

“...Background. Dengue fever is the most common arboviral disease in travelers. In countries where dengue virus is endemic, sequential (secondary) infections with...”

Fulltext

Journal Article

Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study

by Bouchaud, Olivier Mühlberger, Nikolai Parola, Philippe Calleri, Guido Matteelli, Alberto Peyerl-Hoffmann, Gabriele Méchaï, Frédéric Gautret, Philippe Clerinx, Jan Kremsner, Peter G Jelinek, Tomas Kaiser, Annette Beltrame, Anna Schmid, Matthias L Kern, Peter Probst, Meike Bartoloni, Alessano Weinke, Thomas Grobusch, Martin P Published in Malaria journal (2012)

“...Background: Malaria continues to be amongst the most frequent infectious diseases imported to Europe. Whilst European treatment guidelines are based on data...”

Fulltext

Journal Article

Correction: The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases

by Mangen, Marie-Josée J Plass, Dietrich Havelaar, Arie H Gibbons, Cheryl L Cassini, Alessandro Mühlberger, Nikolai van Lier, Alies Haagsma, Juanita A Brooke, R. John Lai, Taavi de Waure, Chiara Kramarz, Piotr Kretzschmar, Mirjam E. E Published in PloS one (20.12.2013)

“...PLoS ONE 8(11): e79740. doi:10.1371/journal.pone.0079740 In the Affiliation, the line "Membership of the Mouse Genome Sequencing Consortium is provided in the...”

Fulltext

Journal Article

Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop

by Wichmann, Ole Jelinek, Tomas Peyerl-Hoffmann, Gabriele Mühlberger, Nikolai Grobusch, Martin P Gascon, Joaquim Matteelli, Alberto Hatz, Christoph Laferl, Hermann Schulze, Marco Burchard, Gerd da Cunha, Saraiva Beran, Jiøi McWhinney, Paul Kollaritsch, Herwig Kern, Peter Cuaos, Juan Alifrangis, Michael Gjørup, Ida Published in Malaria journal (2003)

“...BACKGROUND: Malaria parasites that carry the DHFR-mutation I164L are not only highly resistant to sulfadoxine-pyrimethamine but also to the new antimalarial...”

Fulltext

Narrow search